Skip to main content
BIOLIFE SOLUTIONS INC logo

BIOLIFE SOLUTIONS INC — Investor Relations & Filings

Ticker · BLFS ISIN · US09062W2044 LEI · 549300G2IVCMC2TJDW72 US Manufacturing
Filings indexed 1,453 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US BLFS

About BIOLIFE SOLUTIONS INC

https://www.biolifesolutions.com/

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy (CGT), regenerative medicine, and biobanking markets. The company's portfolio is focused on protecting the integrity and viability of biologics throughout manufacturing and delivery. Key products include proprietary, GMP-compatible biopreservation media (such as CryoStor® freeze media and HypoThermosol® storage media), cell culture optimization products, and innovative storage systems. BioLife Solutions also provides closed-system manufacturing tools and regulatory support to help bioprocess engineers and therapy developers streamline workflows, enhance process efficiency, and ensure reproducibility from research and development through to commercial-scale production.

Recent filings

Filing Released Lang Actions
10-Q - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K
Regulatory Filings
2026-05-07 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-06 English
10-K/A
Annual Report
2026-04-28 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-03-26 English
4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
Director's Dealing
2026-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.